🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
316,13 USD
Máx. histórico
322,75
5 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,05%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+0,83%
Cierre anterior
313,52
Rango de hoy
309,86 – 319,18
Volumen hoy
179.912
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 124,46 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 1 día
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/09/1996 | 45,38 | 45,85 | 44,92 | 45,38 | +0,00% | 2,06% | 8.629 |
| 03/09/1996 | 44,92 | 45,85 | 43,98 | 45,38 | -0,51% | 4,17% | 21.480 |
| 30/08/1996 | 44,92 | 46,79 | 44,92 | 45,62 | -0,51% | 4,17% | 12.851 |
| 29/08/1996 | 47,72 | 49,59 | 44,92 | 45,85 | -7,55% | 9,80% | 28.240 |
| 28/08/1996 | 49,59 | 49,59 | 47,72 | 49,59 | +0,95% | 3,77% | 10.286 |
| 27/08/1996 | 48,66 | 49,59 | 47,26 | 49,13 | +0,96% | 4,81% | 19.183 |
| 26/08/1996 | 48,66 | 49,59 | 46,79 | 48,66 | +0,00% | 5,77% | 17.419 |
| 23/08/1996 | 48,66 | 48,66 | 46,79 | 48,66 | +2,97% | 3,85% | 9.565 |
| 22/08/1996 | 46,79 | 49,59 | 45,85 | 47,26 | +3,06% | 8,00% | 42.747 |
| 21/08/1996 | 45,85 | 46,79 | 44,92 | 45,85 | -1,01% | 4,08% | 25.621 |
| 20/08/1996 | 45,85 | 47,72 | 43,98 | 46,32 | +5,32% | 8,16% | 27.678 |
| 19/08/1996 | 44,45 | 45,38 | 43,51 | 43,98 | +0,00% | 4,21% | 51.643 |
| 16/08/1996 | 44,45 | 44,45 | 43,04 | 43,98 | -1,05% | 3,16% | 7.588 |
| 15/08/1996 | 44,45 | 44,45 | 43,04 | 44,45 | +3,26% | 3,16% | 4.943 |
| 14/08/1996 | 44,45 | 44,45 | 43,04 | 43,04 | -3,16% | 3,16% | 16.217 |
| 13/08/1996 | 44,45 | 45,85 | 43,04 | 44,45 | -3,06% | 6,32% | 19.877 |
| 12/08/1996 | 47,72 | 47,72 | 44,45 | 45,85 | -1,01% | 6,86% | 13.919 |
| 09/08/1996 | 48,19 | 48,19 | 46,32 | 46,32 | -3,88% | 3,88% | 10.660 |
| 08/08/1996 | 48,19 | 48,19 | 47,26 | 48,19 | +0,00% | 1,94% | 4.034 |
| 07/08/1996 | 49,13 | 49,13 | 47,26 | 48,19 | -0,96% | 3,81% | 17.419 |
| 06/08/1996 | 46,32 | 48,66 | 45,38 | 48,66 | +6,12% | 7,07% | 19.770 |
| 05/08/1996 | 45,38 | 46,79 | 45,38 | 45,85 | -0,51% | 3,09% | 10.954 |
| 02/08/1996 | 45,85 | 46,79 | 44,92 | 46,09 | +0,51% | 4,08% | 14.774 |
| 01/08/1996 | 45,85 | 45,85 | 43,98 | 45,85 | +0,00% | 4,08% | 13.626 |
| 31/07/1996 | 43,98 | 45,85 | 43,98 | 45,85 | +4,26% | 4,26% | 28.346 |
| 30/07/1996 | 44,92 | 46,32 | 43,98 | 43,98 | -2,59% | 5,21% | 9.458 |
| 29/07/1996 | 45,85 | 46,32 | 44,92 | 45,15 | -0,52% | 3,06% | 21.160 |
| 26/07/1996 | 43,98 | 45,38 | 43,98 | 45,38 | +0,00% | 3,19% | 19.984 |
| 25/07/1996 | 43,98 | 45,85 | 43,51 | 45,38 | +5,43% | 5,32% | 26.690 |
| 24/07/1996 | 42,58 | 43,04 | 40,24 | 43,04 | -4,17% | 6,59% | 33.797 |